Re: Early relapses after the first dose of natalizumab in active multiple sclerosis

Multiple Sclerosis

Volumn 15, Issue 4, 2009, Pages 520-

  Haartsen, Jodi ^a   Marriott, M ^a   Butzkueven, H ^a  

^a BOX HILL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; NATALIZUMAB;

ABNORMAL SENSATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; FATIGUE; FECES INCONTINENCE; HUMAN; LETTER; LIMB WEAKNESS; MULTIPLE SCLEROSIS; NEUROPATHIC PAIN; OPTIC NEURITIS; RELAPSE; TREATMENT DURATION;

ANTIBODIES, MONOCLONAL; HUMANS; MULTIPLE SCLEROSIS; RECURRENCE;

EID: 63449090674     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508100036     Document Type: Letter

References (1)

1. Centonze, D, Furlan, R, Gasperini, C, Salvetti, M, Battistini, L. Early relapses after the first dose of natalizumab in active multiple sclerosis patients. Mult Scler 2008; 14: 1137-1138.